NASDAQ · Biotechnology

CGEN (CGEN) Stock

$2.27 -4.83% NASDAQ: CGEN Healthcare

Valuation

MetricValue
Price$2.27
Market Cap$214.16M
P/E Ratio7.21
P/B Ratio2.52
P/S Ratio3.52
EPS (TTM)$0.38
52-Week High$3.24
52-Week Low$1.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE33.98%
ROA22.29%
ROCE30.10%
Gross Margin43.84%
Operating Margin42.47%
Net Margin47.97%
Debt/Equity0.03
Current Ratio6.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$8.0M$33.0M$28.0M$73.0M
Operating Profit$-35.0M$-35.0M$-13.0M$-15.0M$31.0M
Net Profit$-34.0M$-34.0M$-19.0M$-14.0M$35.0M
EPS$-0.41$-0.39$-0.21$-0.16$0.38
Op Margin-584.6%-471.6%-38.8%-53.4%43.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$132.0M$94.0M$121.0M$115.0M$157.0M
Total Liabilities$25.0M$16.0M$56.0M$60.0M$54.0M
Cash$8.0M$11.0M$14.0M$18.0M$91.0M
Borrowings$3.0M$2.0M$1.0M$3.0M$3.0M

Latest News

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress PR Newswire · Jun 18, 2026 Compugen (CGEN) Stock Faces Mixed Analyst Target Changes After Cautious Valuation Revisions Simply Wall St. · Jun 18, 2026 Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 PR Newswire · Jun 11, 2026 Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development PR Newswire · Jun 8, 2026 Why The Narrative Around Compugen (NasdaqCM:CGEN) Is Shifting After Analyst Resets And New Views Simply Wall St. · Jun 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-35.0M$-36.0M$50.0M$32.0M
Investing Cash Flow$6.0M$37.0M$35.0M$-46.0M$30.0M
Financing Cash Flow$2.0M$0$0$0$0
Net Cash Flow$1.0M$3.0M$3.0M$4.0M$72.0M
Free Cash Flow$-23.0M$-35.0M$-36.0M$49.0M$31.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA5.52
FCF Yield0.00%
Quick Ratio6.23
Interest Coverage—
Return 1Y49.04%
Return 3Y108.93%
Return 5Y-66.33%

Ownership

Insiders Held2.08%
Institutions Held15.42%
Institutions Float Held15.75%
Institutional HolderSharesReport Date
SilverArc Capital Management, LLC3,315,8452026-03-31
Renaissance Technologies, LLC1,632,9882026-03-31
Morgan Stanley1,053,2292026-03-31
ARK Investment Management, LLC1,049,8732026-03-31
Nomura Asset Management International Inc1,020,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRBP $9.11 +0.33% -1.95 $168.79M 0.00%
CRDF $0.81 -2.98% -2.58 $53.22M 0.00%
CYBNCybin Inc. $8.28 +1.22% -1.67 $413.02M 0.00%
IPHAInnate Pharma S.A. $1.79 +0.14% -2.89 $168.32M 0.00%
MIST $1.13 -2.59% -2.00 $97.05M 0.00%

About CGEN

CGEN is led by CEO Eran Ophir, employs 74 people, headquartered in IL, publicly traded since 2000.

CGEN stock trades at $2.27 with a market capitalization of $214.16M. The stock is valued at a price-to-earnings (P/E) ratio of 7.21, price-to-book of 2.52, price-to-sales of 3.52. Over the past 52 weeks the stock has ranged between $1.30 and $3.24, and currently trades 29.9% below its 52-week high.

On profitability, CGEN generates a return on equity (ROE) of 33.98% — well above the market average, a sign of a high-quality business, return on capital employed of 30.10%, an operating margin of 42.47%, a net profit margin of 47.97%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides